Maximilian Boesch Institute of Immunobiology Kantonsspital St. Gallen Biography Publications Institution JoVE Articles Maximilian Boesch has not added a biography. If you are Maximilian Boesch and would like to personalize this page please email our Author Liaison for assistance. Publications Heterogeneity of Cancer Stem Cells: Rationale for Targeting the Stem Cell Niche Biochimica Et Biophysica Acta. Dec, 2016 | Pubmed ID: 27751894 Ionophore Antibiotics As Cancer Stem Cell-Selective Drugs: Open Questions The Oncologist. Aug, 2016 | Pubmed ID: 27486200 High Prevalence of Side Population in Human Cancer Cell Lines Oncoscience. 2016 | Pubmed ID: 27226981 Optimized Stem Cell Detection Using the DyeCycle-Triggered Side Population Phenotype Stem Cells International. 2016 | Pubmed ID: 26798352 Drug Transporter-Mediated Protection of Cancer Stem Cells From Ionophore Antibiotics Stem Cells Translational Medicine. Sep, 2015 | Pubmed ID: 26136502 The Side Population of Ovarian Cancer Cells Defines a Heterogeneous Compartment Exhibiting Stem Cell Characteristics Oncotarget. Aug, 2014 | Pubmed ID: 25216521 Protein Signatures of Oxidative Stress Response in a Patient Specific Cell Line Model for Autism Molecular Autism. Feb, 2014 | Pubmed ID: 24512814 DyeCycle Violet Used for Side Population Detection is a Substrate of P-glycoprotein Cytometry. Part A : the Journal of the International Society for Analytical Cytology. Jun, 2012 | Pubmed ID: 22407964 Användning av DNA-färgutlösad sidob populationsfenotyp för att detektera och rena cancer stamceller från biologiska prov Maximilian Boesch*1,2,3, Elisabeth Hoflehner2,3, Dominik Wolf2,3,4, Guenther Gastl2, Sieghart Sopper*2,3 1Institute of Immunobiology, Kantonsspital St. Gallen, 2Internal Medicine V, Medical University of Innsbruck, 3Tyrolean Cancer Research Institute (TKFI), 4Medical Clinic III, Oncology, Hematology, Immunoncology and Rheumatology, University Clinic Bonn (UKB) JoVE 55634 Cancer Research
Användning av DNA-färgutlösad sidob populationsfenotyp för att detektera och rena cancer stamceller från biologiska prov Maximilian Boesch*1,2,3, Elisabeth Hoflehner2,3, Dominik Wolf2,3,4, Guenther Gastl2, Sieghart Sopper*2,3 1Institute of Immunobiology, Kantonsspital St. Gallen, 2Internal Medicine V, Medical University of Innsbruck, 3Tyrolean Cancer Research Institute (TKFI), 4Medical Clinic III, Oncology, Hematology, Immunoncology and Rheumatology, University Clinic Bonn (UKB) JoVE 55634 Cancer Research
